Shuttle Pharmaceuticals Holdings, Inc. (NasdaqCM: SHPH)
Health Care · Biotechnology · US
$5.08
-4.69% today · -86.2% 1Y
Shuttle Pharmaceuticals Holdings, Inc. (NasdaqCM: SHPH) operates in the Biotechnology industry within the Health Care sector. The company is valued at $24.20M and employs 2 people.
Over the last twelve months the share price has lost 86.2%, trading between 2.58 and 44.40.
Tweenvest scores Shuttle Pharmaceuticals Holdings, Inc. across four factors: quality 22/100, value 89/100. Its strongest factor is value.
SHPH price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $24.20M
- Revenue (TTM)
- —
- P/E
- —
- EPS
- -20.30
- Dividend yield
- —
- Beta (5Y)
- 1.14
- 52-week high
- $44.40
- 52-week low
- $2.58
- Avg volume (3M)
- —
- Shares outstanding
- 4.76M
- Employees
- 2
- Next earnings
- —
About Shuttle Pharmaceuticals Holdings, Inc.
Shuttle Pharmaceuticals Holdings, Inc., a clinical stage pharmaceutical company, develops novel therapies to treat cancers. It owns a pharmaceutical software artificial intelligence (AI) driven platform for molecular discovery and early-stage drug development. The company was founded in 2012 and is headquartered in Gaithersburg, Maryland.
- ISIN
- US8256935003
- Founded
- 2012
- Listed since
- Aug 31, 2022
- Exchange
- Nasdaq Capital Market
- Currency
- USD
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Lukas Biomedical Inc.TPEX: 6814 | $24.52M | NT$19.00 | +2.70% |
| Original BioMedicals Co., Ltd.TPEX: 6483 | $24.50M | NT$11.90 | +3.93% |
| Ribomic Inc.TSE: 4591 | $24.36M | ¥68.00 | -4.23% |
| Polyrizon Ltd.NasdaqCM: PLRZ | $24.29M | $10.00 | +11.26% |
| Eutilex.Co.,LtdKOSDAQ: A263050 | $24.14M | ₩— | — |
| ABVC BioPharma, Inc.NasdaqCM: ABVC | $23.80M | $0.92 | -8.21% |
| Xbrane Biopharma AB (publ)OM: XBRANE | $23.72M | Skr11.40 | -18.28% |
| GeneMatrix Inc.KOSDAQ: A109820 | $23.69M | ₩1,549.00 | -9.94% |
Figures last refreshed Oct 18, 2026.